Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
- PMID: 25535471
- PMCID: PMC4268561
- DOI: 10.1016/j.jgr.2014.07.002
Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study
Abstract
Background: Many patients with glaucoma have difficulty using antiglaucoma eye drops because of dry eye symptom. In this prospective, randomized, double-blind, placebo-controlled study, we evaluated the effect of Korean Red Ginseng on dry eye syndrome in patients with glaucoma treated with antiglaucoma eye drops.
Methods: Forty-nine participants were allocated to the Korean Red Ginseng (3 g/day; n = 24) or placebo (n = 25) groups for 8 weeks. Tear film stability, fluorescein corneal staining, conjunctival hyperemia, tear production, grade of meibomian gland dysfunction, and dry eye questionnaire (Ocular Surface Disease Index) were evaluated at baseline and on completion of the treatment.
Results: Almost all patients displayed dry eye symptoms and signs at baseline. After the 8-week intervention, Korean Red Ginseng supplementation significantly improved the tear film stability and total Ocular Surface Disease Index score, as compared to placebo (p < 0.01).
Conclusion: Korean Red Ginseng supplementation may provide an additional treatment option for dry eye and patients with glaucoma using antiglaucoma eye drops.
Keywords: Korean Red Ginseng; Panax ginseng; dry eye syndrome; glaucoma.
Figures
References
-
- Pizzarello L., Abiose A., Ffytche T., Duerksen R., Thulasiraj R., Taylor H., Faal H., Rao G., Kocur I., Resnikoff S. VISION 2020: the Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthal. 2004;122:615–620. - PubMed
-
- Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., 2nd, Wilson M.R. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthal. 2002;120:714–720. - PubMed
-
- Higginbotham E.J., Schuman J.S., Goldberg I., Gross R.L., VanDenburgh A.M., Chen K., Whitcup S.M. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthal. 2002;120:1286–1293. - PubMed
-
- Camras C.B. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996;103:138–147. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
